Head of Iran’s Food and Drug Administration said that Iran’s import in medicine and medical equipment had reduced sharply due to the importance of local production in the last two years.
Attending a press conference on Saturday morning in Tehran, Mohammadreza Shanehsaz highlighted the pressure imposed on Iran due to sanctions, adding that Food and Drug Administration (FDA) made its efforts to create opportunities and decrease imports significantly.
Referring to the remarks of the Leader of the Islamic Revolution Ayatollah Sayyed Ali Khamenei about focusing on local production, Shanehsaz noted that domestic companies had taken effective steps, and the indigenous production increased up to 92% in various areas.
Regarding the coronavirus pandemic, FDA’s head added: "We knew that our enemies would cause trouble for us, so we focused on domestic production and produced all the necessary medicine in less than three months."
Mohammadreza Shanehsaz referred to Iran’s mass production of coronavirus vaccine in June, expressing hope that all Iranians would be vaccinated by the end of the 1400 Iranian year (March 20, 2022).
FDA’s head pointed to the unfair distribution of coronavirus vaccine across the world, stressing that Iran did its best to pay for COVAX but did not receive the expected supply.
Although the coronavirus vaccine is in the government’s hands, Iran welcomes any private company which can import it.
Until now, 49 companies have expressed readiness to import the vaccine, and 35 introduction documents were issued for that, but yet none of them could take major steps, Shanehsaz concluded.